ARS Pharmaceuticals Inc (NASDAQ:SPRY) currently has a daily average trading volume of 1.16M but it saw 1834481 shares traded in last market. With a market cap of 1.37B USD, the company’s current market price of $14.11 came rising about 0.21 while comparing to the previous closing price of $14.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $18.51 and as low as $4.01. In the recent trading on the day, stock has struck highest price mark of $13.985 while lowest mark touched by it was $15.25.
Taking a look at 20-day trading activity of ARS Pharmaceuticals Inc (SPRY) gives us an average price of $15.59, while its current price level is -23.77% below from 52-week high level whereas it is 251.87% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $14.58 while that of 200 days or SMA-200 reads an average of $10.75. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.07% during that period while stretching the period over a month that decreases to 7.23%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.46 which implies that the stock is in neutral territory.
Raymond James upgraded its recommendation for the stock as a “Strong Buy” from “Outperform” on August 13, 2024 while assigning a price target range of $18-$22. Leerink Partners issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $19 and $20.
Over the week, SPRY’s stock price is moving -12.58% down while it is -14.59% when we observe its performance for the past one month. Year-to-date it is 157.48% up and over the past year, the stock is showing an upside performance of 233.57%.
Currently, ARS Pharmaceuticals Inc’s total number of outstanding shares is 96.41M. Company’s return on investment (ROI) stands at -24.43% and return on equity (ROE) at -22.41%. Stock’s beta reads 0.86. Stock has a price to book (P/B) ratio of 6.82 while price to sale or P/S ratio amounts to 532.24. Its return on asset (ROA) is -21.07% on average.
